BICO Group AB (publ) (OTCMKTS:CLLKF) Shares Down 3.7% – Here’s Why

BICO Group AB (publ) (OTCMKTS:CLLKF) shares traded down 3.7% on Tuesday . The company traded as low as C$1.52 and last traded at C$1.52. Approximately 300 shares changed hands during mid-day trading, a decline of 97% from the average session volume of 9,650 shares. The stock had previously closed at C$1.58.

BICO Group AB (publ) Stock Performance

The stock’s 50-day moving average is C$1.94 and its 200-day moving average is C$2.03.

BICO Group AB (publ) Company Profile

BICO Group AB (publ), formerly known as CELLINK AB, is a biotechnology company specializing in the development and commercialization of tools and solutions for life science research. The company’s core offerings include advanced 3D bioprinters, proprietary bioinks, microfluidic devices and cell analytics instruments. These technologies are designed to accelerate drug discovery, tissue engineering and personalized medicine by enabling researchers to create and analyze complex biological models in vitro.

In addition to its flagship bioprinting platforms, BICO provides a broad portfolio of consumables and software that support end-to-end workflows for cell culture and bioprocessing.